ROIV: Roivant Sciences Ltd
ROIV exchange rate has changed by -3.22% for today. During the day, the instrument was traded at a low of 28.56 and at a high of 29.64.
Follow Roivant Sciences Ltd dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ROIV News
- Roivant Sciences Ltd. (ROIV) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
- Roivant: Immunovant's Rheumatoid Arthritis Win Validates The Buy (NASDAQ:ROIV)
- Roivant Sciences Ltd. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ROIV) 2026-05-21
- These Two Biotech Stocks Rocketed — And One Just Broke Out
- Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates
- Montes Archimedes Acquisition (ROIV) Upgraded to Buy: Here's Why
- Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
- Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates
- Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- Fate Therapeutics (FATE) Reports Q1 Loss, Misses Revenue Estimates
- Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue Estimates
- Zealand Pharma A/S (ZLDPF) Reports Q1 Loss, Lags Revenue Estimates
- Roivant Sciences: Moderna Settlement, Brepocitinib Support A Long-Term Buy (NASDAQ:ROIV)
- Montes Archimedes Acquisition (ROIV) Upgraded to Buy: Here's What You Should Know
- Roivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data Update - Slideshow (NASDAQ:ROIV) 2026-04-04
- Roivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data Update Transcript
- Tracking David Einhorn's Greenlight Capital Portfolio - Q4 2025 Update (NYSE:GRBK)
Frequently Asked Questions
What is ROIV stock price today?
Roivant Sciences Ltd stock is priced at 28.58 today. It trades within 28.56 - 29.64, yesterday's close was 29.53, and trading volume reached 9074. The live price chart of ROIV shows these updates.
Does Roivant Sciences Ltd stock pay dividends?
Roivant Sciences Ltd is currently valued at 28.58. Dividend policy depends on the company, while investors also watch 56.09% and USD. View the chart live to track ROIV movements.
How to buy ROIV stock?
You can buy Roivant Sciences Ltd shares at the current price of 28.58. Orders are usually placed near 28.58 or 28.88, while 9074 and -3.15% show market activity. Follow ROIV updates on the live chart today.
How to invest into ROIV stock?
Investing in Roivant Sciences Ltd involves considering the yearly range 18.27 - 32.79 and current price 28.58. Many compare -1.99% and 31.46% before placing orders at 28.58 or 28.88. Explore the ROIV price chart live with daily changes.
What are Roivant Sciences Ltd stock highest prices?
The highest price of Roivant Sciences Ltd in the past year was 32.79. Within 18.27 - 32.79, the stock fluctuated notably, and comparing with 29.53 helps spot resistance levels. Track Roivant Sciences Ltd performance using the live chart.
What are Roivant Sciences Ltd stock lowest prices?
The lowest price of Roivant Sciences Ltd (ROIV) over the year was 18.27. Comparing it with the current 28.58 and 18.27 - 32.79 shows potential long-term entry points. Watch ROIV moves on the chart live for more details.
When did ROIV stock split?
Roivant Sciences Ltd has gone through stock splits historically. These changes are visible in , 29.53, and 56.09% after corporate actions.
- Previous Close
- 29.53
- Open
- 29.51
- Bid
- 28.58
- Ask
- 28.88
- Low
- 28.56
- High
- 29.64
- Volume
- 9.074 K
- Daily Change
- -3.22%
- Month Change
- -1.99%
- 6 Months Change
- 31.46%
- Year Change
- 56.09%
- Act
- Fcst
- Prev